Of 62 patients (mean age 75, range 65-92 years) referred to an out-patient anticoagulant clinic specifically for those aged 65 years or more, treatment was considered unsafe in only one patient and was discontinued. Minor bleeding which did not require a significant change in management was recorded on 25 (7%) of 381 clinic visits and one major haemorrhage occurred requiring emergency hospital admission. Anticoagulation was maintained within the therapeutic range on 284 (75%) visits. The results confirm that with appropriate out-patient care and supervision, the risks of oral anticoagulant therapy in the elderly need be no greater than in younger patients.
Introduction
Oral anticoagulants are frequently indicated for the treatment of venous and arterial thrombo-embolism in the elderly. Some authorities however suggest that the risk associated with their use in older patients generally outweighs the potential benefit. 1 Certainly, recent studies suggest at least an eight-to tenfold increase in the incidence of intracranial haemorrhage in elderly patients during anticoagulant treatment, though the risk of bleeding was not specifically related to age, but rather to other coincidental factors.2'3 Increased sensitivity to warfarin,4 the presence of multiple pathology5 and the frequency of polypharmacy with the danger of drug interactions6 are particular problems in the aged and considerable time and effort is needed-to educate most patients to follow a clearly defined regimen which will ensure safe and effective anticoagulant control.
Responsibility for management of these patients is usually delegated to junior doctors who may not have had previous experience, are rarely issued with written policy guidelines and who do not stay in the post long enough to develop any expertise. 7 We report here our experience of an anticoagulant clinic specifically for patients 
Results
Of the patients studied, 61 received warfarin and one received nicoumalone. One patient attended the clinic only once and then moved away to a different area. Treatment was considered unsafe in a further patient because of severe mental and physical disability and was discontinued at the second visit.
Indications for anticoagulant treatment are shown in Table I . Thirteen patients (21%) had more than one indication for treatment and 11 patients (18%) had a past history of thromboembolism prior to their present medical problem. Twenty-six patients (42%) had atrial fibrillation when first seen, but in none was it the primary reason for anticoagulation. Other drugs were being taken by all but seven patients, including two on non-steroidal anti-inflammatory drugs and two on H2 receptor blockers. A further eight patients were taking drugs likely to interact with warfarin and nine admitted to regularly consuming alcohol.
At the first visit the mean dose of warfarin being Two patients were found to be mildly iron deficient when first seen and a further three patients developed iron deficiency whilst attending the clinic. All responded successfully to oral iron. Two patients died during the study period; the causes of death were congestive cardiac failure in a patient anticoagulated for recurrent pulmonary embolism, and undiagnosed adenocarcinoma in a patient with deep vein thrombosis. There was one probable thrombo-embolic episode during the study period when a patient taking warfarin for cerebrovascular disease had a transient ischaemic attack. At the time the BCR was below the therapeutic range.
Discussion
Out-patient management of oral anticoagulant therapy and the incidence of complications in the present series of elderly subjects compares favourably with other published studies involving patients of all ages.9- 1 The average daily dose of warfarin required to maintain control was less than is normally required in younger patients, though similar to that previously reported in patients aged 70 years or more. '2 -14 In our clinic, particular attention was given to educating the patients and relatives about their medication and, when necessary, carers were contacted by telephone to confirm compliance and relay any alterations in the dose. We feel the emphasis on communication and patient understanding was the most significant contribution to the satisfactory outcome. The background and experience of the medical staff in the clinic also meant that other medical problems could be managed at the same time as monitoring warfarin therapy, thus reducing the number of hospital visits. Such an approach would be difficult to achieve in a clinic responsible for patients of all ages. In many hospitals staffing levels and patient numbers may be inadequate to justify an anticoagulant clinic specifically for elderly patients and it may then be better to see them in the geriatric out-patient clinic, rather than the general anticoagulant clinic.
Thrombo-embolic events remain a common problem in the elderly and without anticoagulant therapy the resulting morbidity and mortality is significant. At present, however, many clinicians avoid anticoagulating older patients, believing the risks to outweigh the possible benefits. Our experience confirms that with appropriate care and supervision the risks need be no greater than in younger patients. 
